Drug Discovery World

MAY 25, 2023

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. DDW provides an update.

Production 52

Production Reagent DNA Drugs 52

The Pharma Data

JANUARY 24, 2021

With this acquisition, Calibre Scientific bolsters its strength in the chromatography market and continues to broaden its life sciences presence in Europe. With the acquisition of AIT, Calibre Scientific gains a strategic partner to continue its growth in life sciences. LOS ANGELES, Jan. Source link.

Life Science 52

Life Science Reagent Production Manufacturing 52

Drug Discovery World

FEBRUARY 16, 2023

Ahead of SLAS2023 in San Diego, Jill Hronek , SLAS Director, Marketing & Communications, shares her enthusiasm for the opportunities, products, technologies and innovation that this event brings together. Their technologies range from data sciences to cell sciences, reagents to robotics, and microfluidics to virtual reality.

Life Science 52

Life Science Research Production Reagent 52

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

AUGUST 29, 2024

HTS compatible cellular assays Robert G Lowery PhD, President & CEO at BellBrook Labs, comments: “AI and virtual screening are increasing the diversity of targets in drug discovery, but developing virtual hits still requires wet biology, using technologies developed over the last 25 years. The CellXpress.ai

Drugs 59

Drugs Protein Life Science Antibody 59

Drug Discovery World

JANUARY 10, 2023

For over 50 years, Bethyl Laboratories (now a Fortis Life Sciences brand) has been dedicated to improving lives by supporting scientific discovery through qualified antibody products and custom services. Custom antibody development. We are vertically-integrated from immunisation through manufacturing and validation.

Antibody 52

Antibody Protein Reagent Scientist 52

The Pharma Data

JANUARY 31, 2021

The company creation engine will focus on building life sciences startup companies advancing breakthrough applications in genomics. We also look forward to working together with many more leading healthcare companies to jointly promote the development of human wellbeing.”

Genomics 52

Genomics Genome Life Science DNA 52

XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing. We are not developers of diagnostics.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

The Pharma Data

MAY 15, 2023

The Sandoz Board of Directors will have 10 members in total and 3 sub-committees: a Science, Innovation & Development Committee, a Human Capital & ESG Committee and an Audit, Risk & Compliance Committee. She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company.

Sales 40

Sales Production Doctors Doctor 40

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more.

Genomics 244

Genomics Genome Medicine Gene Therapy 244

Drug Discovery World

DECEMBER 13, 2023

This article is sponsored by Fortis Life Sciences. In the ever-evolving landscape of therapeutic development, the role of antibodies has become increasingly apparent. Fortis Life Sciences offers custom antibody discovery and manufacturing services for antibodies and single-domain antibodies, supporting the drug discovery market.

Life Science 59

Life Science Antibody Manufacturing In-Vivo 59

Roots Analysis

AUGUST 28, 2022

70+ spatial Genomics solutions are developed by industry and non-industry players. Presently, over 45 industry and non-industry players across the globe are engaged in the development of spatial omics solutions for spatial phenotyping and profiling of cellular landscape. Likely Growth of the Spatial Omics Solutions Market.

Genome 52

Genome Genomics RNA Genome Project 52

Drug Discovery World

OCTOBER 21, 2022

Accordingly, advances in flow cytometry technology – both in instrumentation and reagent offerings – are enabling researchers to decipher these questions, leading to new discoveries and diagnostic tools. . Best antibody development practices are summarised in Fig. Overview, evolution, trends . Antibody titration .

Reagent 52

Reagent Antibody Drugs Protein 52

XTalks

JANUARY 20, 2021

Access to laboratory reagents, equipment and research subjects is a necessity for researchers to complete their experimental work, as well as care for live cells, plants or animals. The team at iLab responded to this requirement by developing a new standardized iLab module that is now available to customers.

Research 97

Research Reagent Marketing Packaging 97

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. The next presentation attended in this track was the keynote presentation, which was given by Kate Smith, PhD, Head of UK Protein & Cell Sciences at GSK.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

FEBRUARY 27, 2023

“We’re transforming drug discovery, and it all begins in the lab where researchers can leverage multimode plate reader technology like the EnVision Nexus system to increase R&D productivity at nearly every stage of their process,” said PerkinElmer Senior Vice President of Life Sciences Alan Fletcher. “By

Drugs 52

Drugs Life Science Protein Scientist 52

Drug Discovery World

FEBRUARY 15, 2023

Further discovery of PD-1 and CTLA4 as negative immune regulators led to the development of a new class of cancer therapeutics, namely the immune checkpoint inhibitors 5,6. Between 2017 and 2020, the number of IO therapies being developed has increased significantly from 2030 (for 265 targets) to 4,720 (for 504 targets).

Research 52

Research In-Vitro In-Vivo Development 52